Abstract | BACKGROUND: To prevent bio-accumulation of low molecular weight heparins (LMWHs) in patients with decreased kidney function, dosage reduction and anti-Xa monitoring has been suggested. The aim of this study was to investigate the effect of pre-emptive dosage reduction of LMWH on anti-Xa levels. Furthermore, we investigated the association between anti-Xa levels and bleeding, thrombotic events and mortality. METHODS: In this single center study, we followed 499 patients with decreased renal function in whom anti-Xa levels were measured. We observed how many patients had anti-Xa levels that fell within the reference range, with a standard protocol of a pre-emptive dosage reduction of LMWH (25% reduction in patients with an estimated glomerular filtration rate (eGFR) between 30 and 60 ml/min/1.73m2 and a reduction of 50% in patients with an eGFR below the 30 ml/min/1.73m2). Furthermore, Cox proportional hazard analyses were used to estimate hazard ratios to investigate the association between anti-Xa levels and major bleeding, thrombotic events and mortality within three months of follow-up. RESULTS: In a cohort of 499 patients (445 dalteparin and 54 nadroparin users), a pre-emptive dosage reduction of LMWH led to adequate levels of anti-Xa in only 19% of the patients (12% for the dalteparin users and 50% for nadroparin users). We did not find an association between anti-Xa levels and bleeding, thrombosis or mortality. CONCLUSION: Pre-emptive dosage reduction of LMWH leads to low anti-Xa levels in a large proportion, but this was not associated with bleeding, thrombosis or mortality.
|
Authors | Paul Hornung, Meriem Khairoun, Friedo W Dekker, Karin A H Kaasjager, Albert Huisman, Lily Jakulj, Willem Jan W Bos, Frits R Rosendaal, Marianne C Verhaar, Gurbey Ocak |
Journal | PloS one
(PLoS One)
Vol. 15
Issue 10
Pg. e0239222
( 2020)
ISSN: 1932-6203 [Electronic] United States |
PMID | 33001983
(Publication Type: Journal Article)
|
Chemical References |
- Factor Xa Inhibitors
- Heparin, Low-Molecular-Weight
|
Topics |
- Aged
- Cohort Studies
- Dose-Response Relationship, Drug
- Factor Xa Inhibitors
(metabolism)
- Female
- Hemorrhage
(physiopathology)
- Heparin, Low-Molecular-Weight
(adverse effects, metabolism)
- Humans
- Kidney
(drug effects, physiopathology)
- Male
- Middle Aged
- Thrombosis
(physiopathology)
|